Abstract
The extent of injury to the myocardium after infarction - one of the most influential factors in the prognosis — has previously been assessed by CK-MB release curves using serial serum sampling(l). Aim of the present study was to investigate the ability of a single-point measurement of circulating cardiac troponin T (cTnT) concentrations, performed on day of discharge from coronary care unit (CCU), to estimate the infarct size and assess left ventricular (LV) function in patients with acute myocardial infarction (AMI).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Christenson RH, Vollmer RT, Ohman EM et al. Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. Am J Cardiol 2000;85: 543–7.
Wu AHB, Apple FS, Gibier WB et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104–21.
References
Sobel BE, Bresnahan GF, Shell WE, et al. (1972). Estimation of infarct size in man and its relation to prognosis. Circulation 46:640–648.
Vassanelli C, Menegatti G, Nidasio GP, et al. (1987). Comparison of different pharmacological interventions on enzymatic parameters during acute myocardial infarction. Clin Biochem 20:441–447.
Christenson RH, Vollmer RT, Ohman EM, et al. (2000). Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. Am J Cardiol 85: 543–547.
HÖrder M, Hyltoft Petersen P, Thygesen K, et al. (1981). Plasma enzymes in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information. Scand J Clin Lab Invest 41:41–47.
Holman BL, Goldhaber SZ, Kirsch CM, et al. (1982). Measurement of infarct size using single photon emission computed tomography and technetium 99m pyrophosphate: A description of the method and comparison with patients prognosis. Am J Cardiol 50:503–511.
Kaul S (1998). Assessing the myocardium after attempted reperfusion. Should we bother? Circulation 98:625–627.
Grande P, Fischer Hansen B, Christiansen C, et al. (1982). Estimation of acute myocardial infarct size in man by serum CK-MB measurements. Circulation 65:756–764.
Hackel DB, Reimer KA, Ideker RE, et al. (1984). Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation 70:824–835.
Grande P, Christiansen C, Alstrup K (1983). Comparison of ASAT, CK, CK-MB, and LD for the estimation of acute myocardial infarct size in man. Clin Chim Acta 128:329–335.
Burlina A, Rizzotti P, Plebani M, et al. (1984). CPK and CPK-MB in the early diagnosis of acute myocardial infarction and prediction of infarcted area. Clin Biochem 17:356–361.
Al-Saady NM, Camm AJ (1998). New soluble markers for assessment of infarct size. In: Kaski JC, Holt DW, eds. Myocardial damage. Early detection by novel biochemical markers. Kluwer Academic Publishers: Dordrecht, The Netherlands;137–148.
Katus HA, Remppis A, Scheffold T, et al. (1991). Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 67:1360–1367.
Voss EM, Sharkey SW, Gernert AE, et al. (1995). Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseases myocardium. Arch Pathol Lab Med 119:799–806.
Ricchiuti V, Sharkey SW, Murakami MM, et al. (1998). Cardiac troponin I and T alterations in dog hearts with myocardial infarction. Correlation with infarct size. Am J Clin Pathol 110:241–247.
Remppis A, Ehlermann P, Giannitsis E, et al. (2000). Cardiac troponin T levels at 96 hours reflect myocardial infarct size: A pathoanatomical study. Cardiology 93:249–253.
Hammerer-Lercher A, Metzler B, Mair J, et al. (2001). Cardiac troponin T closely correlates with infarct size in a murine model of acute myocardial infarction. Eur Heart J 22(Abstract Suppl):674.
Wagner I, Mair J, Fridrich L, et al. (1993). Cardiac troponin T release in acute myocardial infarction is associated with scintigraphic estimates of myocardial scar. Coron Artery Dis 4:537–544.
Tanaka H, Abe S, Yamashita T, et al. (1997). Serum levels of cardiac troponin I and troponin T in estimating myocardial infarct size soon after reperfusion. Coron Artery Dis 8:433–439.
Hallermayer K, Klenner D, Vogel R (1999). Use of recombinant human cardiac troponin T for standardization of third generation troponin T methods. Scand J Clin Lab Invest 59(suppl 230):128–131.
Alpert J, Thygesen K, et al. for the Joint European Society of Cardiology/American College of Cardiology Committee (2000). Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36:959–969.
Panteghini M, Gerhardt W, Apple FS, et al. (2001). Quality specifications for cardiac troponin assays. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Scientific Division — Committee on Standardization of Markers of Cardiac Damage. Clin Chem Lab Med 39:174–178.
Bavelaar-Croon CDL, Pauwels EKJ, van der Wall EE (2001). Gated single-photon emission computed tomographic myocardial imaging: A new tool in clinical cardiology. Am Heart J 141:383–390.
The Multicenter Posinifarction Research Group (1983). Risk stratification and survival after myocardial infarction. N Engl J Med 309:331–336.
Kroll D, Farah W, McKendall GR, et al. (2001). Prognostic value of stress-gated Tc-99m sestamibi SPECT after acute myocardial infarction. Am J Cardiol 87:381–386.
Swets JA (1988). Measuring the accuracy of diagnostic systems. Science 240:1285–1293.
Wu AHB, Apple FS, Gibier WB, et al. (1999). National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 45:1104–1121.
Mair J, Wagner I, Morass B, et al. (1995). Cardiac troponin I release correlates with myocardial infarction size. Eur J Clin Chem Clin Biochem 33;869–872.
Kragten JA, Hermens WT, van Dieijen-Visser MP (1996). Cardiac troponin T release into plasma after acute myocardial infarction: only fractional recovery compared with enzymes. Ann Clin Biochem 33:314–323.
Rao ACR, Collinson PO, Canepa-Anson R, et al. (1998). Troponin T measurement after myocardial infarction can identify left ventricular ejection of less than 40%. Heart 80:223–225.
Kanna M, Nonogi H, Sumida H, et al. (2001). Usefulness of serum troponin T levels on day three or four in predicting survival after myocardial infarction. Am J Cardiol 87:294–297.
Braunwald E, Kloner RA (1982). The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66:1146–1149.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bonetti, G., Pagani, F., Giubbini, R., Cuccia, C., Panteghini, M. (2004). Single-Point Troponin T Measurement On The Day Of Coronary Care Unit Discharge After Myocardial Infarction Strongly Correlates With Ejection Fraction And Infarct Size By Nuclear Imaging And With CK-MB Release. In: Burtis, C.A., Müller, M.M. (eds) Advances in Critical Care Testing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18480-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-18480-2_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-40752-2
Online ISBN: 978-3-642-18480-2
eBook Packages: Springer Book Archive